ERIS LIFESCIENCES SUPPORTS INNOVATION IN CONTINUING MEDICAL EDUCATION (CME) - LAUNCHES THE FIRST-EVER ‘METABOLIC ROADINAR’
Continuing Medical Education (CME) is an integral part of medical communication targeted to help clinicians improve medical outcomes in patients. Due to restrictions that followed as a result of the Covid19 outbreak, seminars witnessed a shift in their formats, with healthcare professionals adopting webinars as the new platform in the postpandemic era. Now webinars are all set to see a renewed approach towards delivering medical education, and a new term coined to present the format is “Roadinar”. In order to find an innovative solution to maintain high engagement levels in CMES, Eris Lifesciences supports this innovative, firstofitskind initiative presented by the Metabolic Health Digest, the first edition of the Metabolic Roadinar an educational travelogue featuring 18 wellknown doctors from across the country spread across 9 episodes.
Having covered 45,000+ medical practitioners since the start of the pandemic through digital interactions, Eris has been at the forefront in delivering knowledge sessions for doctors in the fields of diabetes, heart failure, Covid impact on cardiometabolic health and general immunity. Eris has carved out a niche for itself in the cardiometabolic space through its unique Patient Care Initiatives platform and ongoing investment in Indiacentric studies to generate cuttingedge scientific evidence based on the local population. An example of this is the India Heart Study (IHS), which is the only study of its kind on hypertension based on the Indian population. In addition to having become a benchmark in its field, the study was accepted and published in the Journal of Hypertension, the official journal of the International Society of Hypertension and the European Society of Hypertension. The Metabolic Roadinar is in line with Eris’ commitment to support innovative thinking and deliver futureforward, critical information to the medical fraternity.
The Roadinar has been conceptualised by Dr. Rajiv Kohli, Diabetologist in Mumbai. The list of 18 doctors who will be a part of this Roadinar includes prominent names such as Dr. Ambrish Mithal, Dr. Shashank Joshi and Dr. Tejas Shah; the Roadinar features doctors from across cities such as Delhi, Mumbai, Ahmedabad, Bangalore, Pune, Aurangabad, and Kolkata. They will be seen discussing varied topics ranging from rediscovering liver as the harbinger of diabetes, COVID Diabetes Mucor Mycosis The boomerang effect of the pandemic, and DPP4 inhibitors + Metformin VERIFYING an extraordinary durability among others.
Speaking about this initiative, Mr Amit Bakshi, Chairman and Managing Director, Eris Lifesciences said, “CME is an integral part of ensuring continuous knowledge building and an effective way to stay abreast with the current and forward looking developments in the medical industry. We want to bring together a fresh perspective and encourage newer ideas. Metabolic Roadinar, is an innovative way of delivering CMES which retains its essence and at the same time opens avenues for disruption in the approach towards CMES in future. We are happy to support innovation in this field and this becomes a trend setter for years to come.”
Speaking about conceptualizing this initiative, Dr Rajiv Kovil, Diabetologist said,” From personal and industry experiences, we have witnessed decreasing engagement of the medical fraternity towards CMES. While each of us understands its relevance and importance, the lack of innovation has made the platform dull and uninspiring. Hence, we were sparked by the thought of introducing CMES in a more fun, lively and human format, which will build excitement. We thank Eris Lifesciences for helping drive this initiative, and hope this becomes the stepping stone for the disruption and evolution of the Indian and global CME landscape in the postpandemic world.”
The first edition of the Metobolic Roadinar will be hosted on a Youtube channel, with one episode being launched every weekend.